Abdu Semah, Xia Jiao, Yuan Huihui, Tan Tiak Ju, Layhadi Janice A, Shamji Mohamed H, McKenzie Andrew N J, Haloob Nora, Hopkins Claire, Woszczek Grzegorz, Till Stephen J
School of Immunology and Microbial Sciences, King's College London, London, UK.
King's Centre for Lung Health, King's College London, London, UK.
Allergy. 2025 Apr;80(4):965-975. doi: 10.1111/all.16472. Epub 2025 Jan 19.
Alarmin cytokine IL-25 promotes type 2 inflammatory responses in disorders such as asthma and chronic rhinosinusitis with nasal polyps (CRSwNP) and known targets include ILC2 and Th2 cells. However, other cellular targets for IL-25 remain poorly defined.
To investigate induction and expression of IL-25 receptor (IL-17RB) by B cells and evaluate responsiveness of IL-17RB-expressing B cells to IL-25 in vitro.
IL-17RB expression, regulation and function on B cells were evaluated in peripheral blood-derived B cells by flow cytometry and RT-PCR, including in response to IgE-inducing stimuli (anti-CD40 mAb and IL-4). Single-cell RNA sequencing was used to compare IL-17RB+ and IL-17RB-activated peripheral blood-derived B cells. To evaluate B cell IL-17RB expression within type 2 inflamed tissue, B cells were compared from nasal polyps, control turbinate tissue and matched peripheral blood.
Activation of B cells with anti-CD40 and IL-4 increased IL-17RB expression at both protein and mRNA level, which was further upregulated by IL-25. B cells induced to express IL-17RB responded to IL-25 with enhanced antibody production. Single-cell RNA-sequencing showed that IL17RB+ activated B cells expressed higher levels of IGHE, CCL17 and CCL22 compared to IL17RB- B cells. B cells from nasal polyp tissue expressed higher levels of surface IL-17RB compared with control tissue, correlating with patient-reported CRSwNP severity (SNOT-22).
Peripheral blood B cells activated under IgE-inducing conditions express surface IL-17RB, and tissue IL-17RB+ B cells are increased in type 2 inflammation. IL-17RB+ cells have a distinct transcriptional profile and respond to IL-25 with enhanced antibody production, highlighting the IL-25/IL-17RB pathway as a potential therapeutic target for CRSwNP and other type 2 inflammatory disorders.
警报素细胞因子白细胞介素-25(IL-25)在哮喘和伴鼻息肉的慢性鼻-鼻窦炎(CRSwNP)等疾病中促进2型炎症反应,已知靶点包括2型固有淋巴细胞(ILC2)和辅助性T细胞2(Th2细胞)。然而,IL-25的其他细胞靶点仍不清楚。
研究B细胞对IL-25受体(IL-17RB)的诱导和表达,并评估体外表达IL-17RB的B细胞对IL-25的反应性。
采用流式细胞术和逆转录-聚合酶链反应(RT-PCR)评估外周血来源的B细胞中IL-17RB的表达、调节及其在B细胞上的功能,包括对诱导IgE产生的刺激(抗CD40单克隆抗体和IL-4)的反应。使用单细胞RNA测序比较IL-17RB⁺和IL-17RB激活的外周血来源的B细胞。为了评估2型炎症组织中B细胞IL-17RB的表达,比较了鼻息肉、对照鼻甲组织和匹配外周血中的B细胞。
用抗CD40和IL-4激活B细胞可增加蛋白和mRNA水平的IL-17RB表达,IL-25可进一步上调其表达。诱导表达IL-17RB的B细胞对IL-25反应,抗体产生增加。单细胞RNA测序显示,与IL-17RB⁻ B细胞相比,IL17RB⁺激活的B细胞表达更高水平的免疫球蛋白E(IGHE)、趋化因子(C-C基序)配体17(CCL17)和趋化因子(C-C基序)配体22(CCL22)。鼻息肉组织中的B细胞比对照组织表达更高水平的表面IL-17RB,这与患者报告的CRSwNP严重程度(鼻窦炎结局测试-22[SNOT-22])相关。
在诱导IgE产生的条件下激活的外周血B细胞表达表面IL-17RB,并且在2型炎症中组织IL-17RB⁺ B细胞增加。IL-17RB⁺细胞具有独特的转录谱,并对IL-25反应,抗体产生增加,突出了IL-25/IL-17RB途径作为CRSwNP和其他2型炎症性疾病的潜在治疗靶点。